Michael Sela | Academic Influence

Michael Sela's AcademicInfluence.com Rankings

Michael Sela

Biology

#523

World Rank

#922

Historical Rank

Immunology

#22

World Rank

#25

Historical Rank

biology Degrees

Download Badge

Biology

Michael Sela's Degrees

PhD Immunology Weizmann Institute of Science

Why Is Michael Sela Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Michael Sela was an Israeli immunologist of Polish Jewish origin. He was the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot. He was a president of the Weizmann Institute of Science.

(See a Problem?)

Michael Sela's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. (1961) (1053)
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. (1996) (817)
Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. (2000) (565)
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. (1999) (490)
Roles for growth factors in cancer progression. (2010) (438)
Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide (1971) (421)
Antigenicity: some molecular aspects. (1969) (393)
GENETIC CONTROL OF THE ANTIBODY RESPONSE (1965) (345)
Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. (2000) (337)
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. (2000) (304)
Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. (1997) (279)
The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities. (1975) (266)
Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. (1988) (252)
Reductive cleavage of disulfide bridges in ribonuclease. (1957) (241)
Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity. (1994) (233)
Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. (2005) (231)
Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ (2003) (229)
The Configurational Changes of Poly-L-proline in Solution (1960) (223)
Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. (2000) (219)
Some spectrophotometric and polarimetric experiments with ribonuclease. (1957) (217)
Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. (1991) (214)
Synthesis and chemical properties of poly-alpha-amino acids. (1958) (210)
Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine. (1962) (209)
Purification of antibodies with immunoadsorbents prepared using bromoacetyl cellulose. (1967) (205)
The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. (2005) (203)
A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors (1997) (194)
Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking. (1999) (187)
Mechanism of adsorption of human albumin to titanium in vitro. (1997) (187)
Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. (1993) (186)
Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1 (1998) (182)
Role of Treponema denticola in periodontal diseases. (2001) (179)
Immunological studies with synthetic polypeptides. (1966) (175)
The correlation of ribonuclease activity with specific aspects of tertiary structure. (1957) (174)
Genetic control of the antibody response. II. Further analysis of the specificity of determinant-specific control, and genetic analysis of the response to (H,G)-A--L in CBA and C57 mice. (1967) (174)
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. (1996) (171)
Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. (1995) (169)
Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis (2009) (166)
A placebo‐controlled, double‐blind, randomized, two‐center, pilot trial of Cop 1 in chronic progressive multiple sclerosis (1991) (164)
Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses (1996) (160)
"Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. (1988) (154)
Antibodies to Sequential and Conformational Determinants (1967) (146)
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. (1971) (141)
REGULATION OF ANTIBODY RESPONSE BY CELLS EXPRESSING HISTAMINE RECEPTORS (1972) (131)
Biological Properties of Poly-α- Amino Acids (1959) (130)
Superoxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis patients. (1991) (129)
New sustained release dosage form of chlorhexidine for dental use. II. Use in periodontal therapy. (1983) (127)
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone® (2001) (126)
Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer. (1974) (124)
A new degradable controlled release device for treatment of periodontal disease: in vitro release study. (1990) (124)
Higher antitumor efficacy of daunomycin when linked to dextran: in vivo and in vitro studies. (1978) (119)
Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen (1973) (118)
Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth (2013) (117)
Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1. (1988) (117)
THE GENETIC CONTROL OF ANTIBODY SPECIFICITY (1969) (116)
The reductive cleavage of disulfide bonds and its application to problems of protein structure. (1959) (114)
Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein. (1992) (113)
The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies. (1975) (113)
Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis (2008) (110)
Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR (2013) (109)
Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. (1999) (108)
Studies on the chemical basis of the antigenicity of proteins. 1. Antigenicity of polypeptidyl gelatins. (1960) (108)
Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. (1992) (108)
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin (1998) (106)
Studies on the structure of poly-L-proline in solution. (1958) (104)
Antibodies to a unique region in lysozyme provoked by a synthetic antigen conjugate. (1969) (103)
Adsorption of human plasma proteins to modified titanium surfaces. (2007) (102)
Efficacy of a sustained-release device containing chlorhexidine and Ca(OH)2 in preventing secondary infection of dentinal tubules. (1992) (101)
Successful immunization with a totally synthetic diphtheria vaccine. (1982) (101)
catELISA: a facile general route to catalytic antibodies. (1993) (100)
In vivo and in vitro immunological cross‐reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis (1973) (98)
Dependence of the chemical nature of antibodies on the net electrical charge of antigens. (1966) (98)
The Terminal Groups of Poly-α-amino Acids (1955) (98)
Caries experience, periodontal treatment needs, salivary pH, and Streptococcus mutans counts in a preadolescent Down syndrome population. (1991) (96)
Basic encephalitogenic protein: A simplified purification on sulphoethyl‐sephadex (1970) (95)
Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy (2003) (94)
Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity? (1995) (93)
THE NATURE OF THE ANTIGENIC DETERMINANT IN A GENETIC CONTROL OF THE ANTIBODY RESPONSE (1969) (91)
Antiviral effect on MS-2 coliphage obtained with a synthetic antigen. (1976) (91)
Microbiological evaluation of the efficacy of chlorhexidine in a sustained-release device for dentine sterilization. (1992) (91)
Co-operative Effects of Functional Groups in Peptides. I. Aspartyl-serine Derivatives (1962) (90)
Proteases of Treponema denticola outer sheath and extracellular vesicles (1995) (89)
The reversible reduction of disulfide bonds in polyalanyl ribonuclease. (1962) (88)
Multiple sclerosis: Trial of a synthetic polypeptide (1982) (88)
Chemical and immunological characterization of a unique antigenic region in lysozyme. (1971) (86)
Accumulation of Streptococcus mutans on light-cured composites and amalgam: an in vitro study. (1998) (84)
GENETIC CONTROL OF THE ANTIBODY RESPONSE (1967) (82)
Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. (1991) (82)
Clinical and microbiological effects of sustained release chlorhexidine in periodontal pockets. (1986) (81)
In Vitro and In Vivo Efficacy of Conjugates of Daunomycin with Anti‐Tumor Antibodies (1982) (81)
A simple fluorescent method to determine complement-mediated liposome immune lysis. (1977) (80)
Adsorption of human salivary proteins to titanium powder. I. Adsorption of human salivary albumin. (1995) (80)
The localization of antigen in relation to specific antibody-producing cells. I. Use of a synthetic polypeptide [(T,G)-A--L] labelled with iodine-125. (1966) (78)
c-Cbl Is a Suppressor of the Neu Oncogene* (2000) (78)
The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: Effect of copolymer 1 on MOG-induced disease (1996) (78)
The Synthesis and Spectrophotometric Study of Poly-L-tyrosine and Poly-3,5-diiodotyrosine1 (1953) (77)
Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier. (1979) (77)
Copolymer 1: from basic research to clinical application (1997) (77)
The role of leukocytes and their hydrolases in the persistence, degradation, and transport of bacterial constituents in tissues: relation to chronic inflammatory processes in staphylococcal, streptococcal, and mycobacterial infections and in chronic periodontal disease. (1976) (76)
Enzymatic degradation of collagen-guided tissue regeneration membranes by periodontal bacteria. (2003) (75)
Preparation of protein-bacteriophage conjugates and their use in detection of anti-protein antibodies. (1970) (74)
USE OF ANTIBODY BOUND TO MODIFIED CELLULOSE AS AN IMMUNOSPECIFIC ADSORBENT OF ANTIGENS. (1963) (74)
The adhesion of oral bacteria to modified titanium surfaces: role of plasma proteins and electrostatic forces. (2013) (73)
Inactivation of poly-DL-alanyl bacteriophage T4 with antisera specific toward poly-DL-alanine. (1966) (72)
Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin. (1983) (72)
Thymus-independence of slowly metabolized immunogens. (1972) (72)
Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells. (1982) (71)
CONTRIBUTION OF DIFFERENT CELL TYPES TO THE GENETIC CONTROL OF IMMUNE RESPONSES AS A FUNCTION OF THE CHEMICAL NATURE OF THE POLYMERIC SIDE CHAINS (POLY-L-PROLYL AND POLY-DL-ALANYL) OF SYNTHETIC IMMUNOGENS (1972) (71)
Immunomodulation by the copolymer glatiramer acetate (2003) (70)
Role of optical configuration in the immunogenicity and specificity of synthetic antigens derived from multichain polyproline. (1968) (68)
Shape and volume of anti-poly(D-alanyl) antibodies in the presence and absence of tetra-D-alanine as followed by small-angle x-ray scattering. (1973) (67)
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis (2012) (67)
The effect in vivo of chemotherapeutic drug—antibody conjugates in two murine experimental tumor systems (1978) (66)
Studies on the chemical basis of the antigenicity of proteins. 6. Antigenic specificity of some synthetic polypeptides containing tyrosine. (1963) (65)
IN VITRO INDUCTION OF A PRIMARY RESPONSE TO THE DINITROPHENYL DETERMINANT (1970) (65)
Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies. (1982) (65)
Synthesis and antigenic properties of sugar-polypeptide conjugates. (1966) (64)
Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor. (1989) (64)
Coaggregation of Porphyromonas gingivalis and Fusobacterium nucleatum PK 1594 is mediated by capsular polysaccharide and lipopolysaccharide. (2006) (64)
Studies on the chemical basis of the antigenicity of proteins. 2. Antigenic specificity of polytyrosyl gelatins. (1960) (63)
Involvement of Toll-Like Receptors 2 and 4 in the Innate Immune Response to Treponema denticola and Its Outer Sheath Components (2009) (63)
Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules. (1999) (62)
A comparison of the physical chemical properties of oxidized and reduced alkylated ribonuclease. (1959) (62)
Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids. (1976) (61)
Combining sites of antibodies with L-alanine and D-alanine peptide specificity and the effect of serum proteolytic activity on their estimation. (1966) (61)
Pericoronitis: a reappraisal of its clinical and microbiologic aspects. (1985) (60)
Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity. (1980) (60)
Inhibition of superoxide production in human polymorphonuclear leukocytes by oral treponemal factors (1988) (60)
The use of sustained release delivery of chlorhexidine for the maintenance of periodontal pockets: 2-year clinical trial. (1991) (59)
On the non-essentiality of two specific disulphide bonds in ribonuclease for its biological activity. (1967) (59)
Anticariogenic activity of licorice and glycyrrhizine I: Inhibition of in vitro plaque formation by Streptococcus mutans. (1985) (59)
Antigenicity of some new synthetic polypeptides and polypeptidyl gelatins. (1964) (59)
The role of CD8+CD28− regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand (2007) (59)
Activation of Murine Macrophages by Lipoprotein and Lipooligosaccharide of Treponema denticola (1999) (58)
Dynamics of hapten-antibody interaction. Studies on a myeloma protein with anti-2,4-dinitrophenyl specificity. (1972) (58)
The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. (1994) (58)
Synthetic antigens composed exclusively of L- or D-amino acids. I. Effect of optical configuration on the immunogenicity of synthetic polypeptides in mice. (1967) (56)
Caries levels, Streptococcus mutans counts, salivary pH, and periodontal treatment needs of adult Down syndrome patients. (1991) (56)
Titration of N-Carboxy-alpha-amino Acid Anhydrides in Nonaqueous Solvents (1953) (55)
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18 (2016) (55)
Cancer therapeutic antibodies come of age: Targeting minimal residual disease (2007) (55)
HLA A9 and B15 are associated with the generalized form, but not the localized form, of early-onset periodontal diseases. (1994) (55)
The effect of urea and guanidine hydrochloride on activity and optical rotation of penicillinase. (1960) (53)
POLYLYSINE-SPECIFIC ANTIBODIES AND THEIR REACTION WITH OLIGOLYSINES. (1965) (53)
Conformational changes in a synthetic antigen induced by specific antibodies. (1971) (53)
Periodontitis associated with Papillon-Lefèvre syndrome. (1990) (52)
Multichain Polyamino Acids (1956) (52)
Therapeutic vaccines in autoimmunity (2004) (52)
Oral treatment of mice with copolymer 1 (glatiramer acetate) results in the accumulation of specific Th2 cells in the central nervous system (2002) (51)
Use of protein-bacteriophage conjugates for detection and quantitation of proteins. (1970) (51)
Recovery of antigenic activity upon reoxidation of completely reduced polyalanyl rabbit immunoglobulin G. (1966) (49)
Studies on the chemical basis of the antigenicity of proteins. 3. The role of rigidity in the antigenicity of polypeptidyl gelatins. (1960) (48)
Sustained release device containing minocycline for local treatment of periodontal disease (1988) (48)
Anti-penicilloyl Antibodies: Detection with Penicilloylated Bacteriophage and Isolation with a Specific Immunoadsorbent (1967) (48)
A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo. (1996) (48)
Adhesion of periodontal bacteria to titanium, and titanium alloy powders. (1998) (48)
CELLULAR BASIS OF THE GENETIC CONTROL OF IMMUNE RESPONSES TO SYNTHETIC POLYPEPTIDES (1971) (48)
Coaggregation of Treponema denticola with Porphyromonas gingivalis and Fusobacterium nucleatum is mediated by the major outer sheath protein of Treponema denticola. (2008) (47)
Antibody combining sites to a series of peptide determinants of increasing size and defined structure. (1970) (46)
CELLULAR BASIS OF THE GENETIC CONTROL OF IMMUNE RESPONSES TO SYNTHETIC POLYPEPTIDES (1970) (46)
Synthetic antigens with sequential and conformation-dependent determinants containing the same L-tyrosyl-L-alanyl-L-glutamyl sequence. (1971) (46)
Effect of carrier on the immunogenic capacity of synthetic cholera vaccine. (1985) (46)
Development of resistant oral viridans streptococci after administration of prophylactic antibiotics: time management in the dental treatment of patients susceptible to infective endocarditis. (1987) (46)
Detection of a fibroblast proliferation inhibitory factor from Capnocytophaga sputigena (1980) (45)
Isolation of antibodies to antigens of low molecular weight. (1962) (45)
A method for the specific proteolytic cleavage of protein chains. (1956) (45)
Prevention of infective endocarditis: not by antibiotics alone. A 7-year follow-up of 90 dental patients. (1986) (44)
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate (2013) (44)
A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells (2003) (44)
Identification of a Fusobacterium nucleatum 65 kDa serine protease. (2004) (43)
Examination of HER3 targeting in cancer using monoclonal antibodies (2015) (43)
Isolation and characterization of active fragments obtained by cleavage of immunoglobulin G with cyanogen bromide. (1966) (43)
Chapter 10 – Polyamino Acids as Protein Models (1964) (43)
Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease. (1997) (43)
Role of leukocyte factors and cationic polyelectrolytes in phagocytosis of group A streptococci and Candida albicans by neutrophils, macrophages, fibroblasts and epithelial cells: modulation by anionic polyelectrolytes in relation to pathogenesis of chronic inflammation. (1981) (42)
The identification of ureactive amino groups in ribonuclease and their significance to enzymatic activity. (1963) (42)
Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis. (1996) (42)
URIDINE-SPECIFIC ANTIBODIES OBTAINED WITH SYNTHETIC ANTIGENS. (1964) (41)
Gram-negative enteric bacteria in the oral cavity of leukemia patients. (1992) (41)
The reformation of disulfide bridges in proteins. (1959) (41)
Actinobacillus actinomycetemcomitans Serotype b Lipopolysaccharide Mediates Coaggregation with Fusobacterium nucleatum (2003) (40)
Adsorption of salivary proteins onto prosthetic titanium components. (1995) (40)
Daunomycin--immunoglobulin conjugates, uptake and activity in vitro. (1978) (40)
Antibodies elicited with conjugates of nucleosides with synthetic polypeptides. (1967) (39)
Synthesis of poly‐L‐lysine and poly‐L‐lysyl albumin via ϵ,N‐trifluoroacetyl‐α,N‐carboxy‐L‐lysine anhydride (1963) (39)
The synthesis and circular dichroism of a series of peptides possessing the structure (L-tyrosyl-L-alanyl-L-glutamyl)n. (1971) (39)
G E N E T I C CONTROL OF T H E ANTIBODY RESPONSE I. DEMONSTRATION OF DETERMINANT-SPECIFIC DIFFERENCES IN RESPONSE TO SYNTHETIC POLYPEPTIDE ANTIGENS IN TWO STRAINS OF INBRED MICE (2003) (39)
Recovery of antibody activity upon reoxidation of completely reduced polyalanyl heavy chain and its Fd fragment derived from anti-2,4-dinitrophenyl antibody. (1968) (39)
The role of thymus cells in the immune response to poly(Tyr, Glu)‐polyD L Ala–polyLys as a function of the genetic constitution of the mouse strain (1974) (39)
Preparation and characterization of poly-DL-alanyl rabbit gamma-globulin. (1965) (38)
Shape and volume of fragments Fab' and (Fab')2 of anti-poly(D-alanyl) antibodies in the presence and absence of tetra-D-alanine as determined by small-angle x-ray scattering. (1975) (38)
Protection against Experimental Allergic Encephalomyelitis (1972) (38)
Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2 (2013) (38)
INHIBITION OF LYSOZYME BY SOME COPOLYMERS OF AMINO ACIDS. (1963) (38)
Determinants of antigenic molecules responsible for genetically controlled regulation of immune responses. (1976) (38)
Anti-inosine antibodies. (1971) (38)
RESOLUTION OF RABBIT GAMMA-GLOBULIN INTO TWO FRACTIONS BY CHROMATOGRAPHY ON DIETHYLAMINOETHYL-SEPHADEX. (1963) (37)
Immunogenicity and Role of Size: Response of Guinea Pigs to Oligotyrosine and Tyrosine Derivatives (1965) (37)
Degradation of collagen-guided tissue regeneration membranes by proteolytic enzymes of Porphyromonas gingivalis and its inhibition by antibacterial agents. (2009) (37)
The localization of antigen in lymph nodes and its relation to specific antibody-producing cells. II. Comparison of iodine-125 and tritium labels. (1967) (37)
A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses. (1997) (37)
Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice. (2000) (37)
Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm (2013) (37)
Adherence of periodontopathic bacteria to bioabsorbable and non-absorbable barrier membranes in vitro. (1999) (36)
ANTIBODY RESPONSE OF INBRED MOUSE STRAINS TO ORDERED TETRAPEPTIDES OF TYROSINE AND GLUTAMIC ACID ATTACHED TO MULTICHAIN POLYALANINE OR POLYPROLINE (1974) (36)
New insights into the mechanism of action of copolymer 1 of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis (1996) (36)
[Strain-dependent differences in the specificity of antibody responses toward lysozyme]. (1971) (35)
Oral Glatiramer Acetate in Experimental Autoimmune Encephalomyelitis: Clinical and Immunological Studies (2004) (35)
Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs. (1993) (35)
Efficiency of different chemical agents in decontamination of gutta-percha cones. (1987) (35)
THYMUS INDEPENDENCE OF A COLLAGEN-LIKE SYNTHETIC POLYPEPTIDE AND OF COLLAGEN, AND THE NEED FOR THYMUS AND BONE MARROW-CELL COOPERATION IN THE IMMUNE RESPONSE TO GELATIN (1974) (34)
Copolymer 1 inhibits manifestations of graft rejection. (2001) (34)
Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells. (1997) (34)
Isolation and characterization of a neurotoxin from Vipera palestinae venom. (1966) (34)
Recovery of specific activity upon reoxidation of completely reduced polyalanyl rabbit antibody. (1966) (34)
The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes (2001) (34)
Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis (2018) (33)
Modification of the carboxyl groups of ribonuclease by attachment of glycine or alanylglycine. (1967) (33)
Lipoproteins of Treponema denticola: their effect on human polymorphonuclear neutrophils. (1997) (33)
A specific synthetic polypeptide antigen. (1960) (33)
Biological and chemical characterization of endotoxin from Capnocytophaga sputigena. (1980) (33)
Synthetic Copolymer I and Myelin Basic Protein Do Not Require Processing Prior to Binding to Class II Major Histocompatibility Complex Molecules on Living Antigen-Presenting Cells (1995) (32)
Roles for Growth Factors in Cancer (2010) (32)
Extrinsic Cotton effect and immunological properties of the p-azobenzenearsonate hapten attached to a helical amino acid copolymer. (1970) (32)
IMMUNE RESPONSE TO POLYPEPTIDYL PROTEINS IN RABBITS TOLERANT TO THE PROTEIN CARRIERS. (1964) (32)
Therapeutic vaccines: Realities of today and hopes for tomorrow (2004) (31)
Inactivation of bacteriophage T4, of poly-D-alanyl bacteriophage and of penicilloyl bacteriophage by immunospecifically isolated IgM and IgG antibodies. (1969) (31)
Indirect immunotargeting of CIS‐PT to human epidermoid carcinoma KB using the avidin‐biotin system (1991) (31)
Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides. (1984) (31)
Fab dimers of antitumor immunoglobulins as covalent carriers of daunomycin. (1976) (31)
Immunological properties of a collagen-like synthetic polypeptide. (1969) (31)
Sequential manifestation of different forms of early-onset periodontitis. A case report. (1994) (30)
IgG and IgM antibodies in normal and leukaemic cattle. (1976) (30)
Enzymatic activity of polyalanyl ribonuclease. (1963) (30)
An ultracentrifugal study of the efficiency of some macromolecular inhibitors of ribonuclease (1962) (29)
Preferential formation of antibodies specific toward D-amino acid residues upon immunization with poly-DL-peptidyl proteins. (1967) (29)
Cytolipin H-specific antibodies obtained with a synthetic polypeptide conjugate. (1967) (29)
Specific excitation energy transfer from antibodies to dansyl-labeled antigen. Studies with the "loop" peptide of hen egg-white lysozyme. (1971) (29)
Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance. (2011) (28)
The specificity of cellular immunity: studies in guinea pigs using defined tetrapeptides containing p‐azobenzenearsonate‐L‐tyrosine (1973) (28)
Characterization of fibrinolytic activities of Treponema denticola (1994) (28)
STUDIES ON THE COMPETENCE OF SINGLE CELLS TO PRODUCE ANTIBODIES OF TWO SPECIFICITIES (1968) (28)
Characterization of treponemes isolated from human and non-human primate periodontal pockets. (1987) (28)
Combining sites of IgG and IgM antibodies of poly-D-alanyl specificity. (2005) (28)
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate (2014) (27)
Use of urea in the purification of antibodies. (1965) (27)
Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase. (1994) (27)
Pyridoxal-specific antibodies obtained with a synthetic pyridoxal-polypeptide conjugate. (1966) (27)
Formation and isolation of rabbit antibodies to a synthetic antigen of low molecular weight. (1967) (27)
Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells. (2005) (27)
Immunochemical detection of prostaglandins with prostaglandin-coated bacteriophage T 4 and by radioimmunoassay. (1972) (27)
The covalent linking of two nucleotide analogues to antibodies. (1985) (26)
On immunological cross-reactions between the synthetic ordered polypeptide (L-Pro-Gly-L-Pro)n and several collagens. (1973) (26)
THE MECHANISM OF POLYMERIZATION OF N-CARBOXY-α-AMINO ACID ANHYDRIDES (1953) (25)
Specific vaccines against autoimmune diseases. (1999) (25)
Antigen design and immune response. (1973) (25)
Wettability versus electrostatic forces in fibronectin and albumin adsorption to titanium surfaces. (2012) (25)
Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis. (2005) (25)
Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies (2000) (25)
Sphingomyelin specific antibodies elicited by synthetic conjugates. (1973) (25)
Immunological comparison of bird and human lysozymes and of their "loop" regions. (1970) (25)
The Properties of Poly-dl-alanyl Trypsin and Poly-dl-alanyl Chymotrypsin (1962) (25)
Effect of Amine- and Stannous Fluoride on Human Neutrophil Functions in vitro (1997) (25)
Clinical and microbial considerations for the treatment of an extended kindred with seven cases of prepubertal periodontitis: a 2-year follow-up. (1997) (24)
New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis. (1996) (24)
Inhibition of ribonuclease by copolymers of glutamic acid and aromatic amino acids. (1962) (24)
Lymphocytes sensitised to basic encephalitogen in patients with multiple sclerosis unresponsive to steroid therapy. (1974) (24)
Copolymer 1 from the laboratory to FDA. (1997) (23)
Relation between optical configuration and immunogenicity of synthetic polypeptides. (1965) (23)
Genetically controlled immune responses of inbred mouse strains to conjugates of the ordered peptides (Tyr‐Tyr‐Glu‐Glu) and (Tyr‐Glu‐Tyr‐Glu) with multichain poly‐DL‐alanine as compared with the response to the random (T, G)‐A‐‐L (1975) (23)
Advances in Brief Tumor-inhibitory Antibodies to HER-2 / ErbB2 May Act by Recruiting c-Cbl and Enhancing Ubiquitination of HER-21 (2000) (23)
A sensitive technique for detecting and estimating the peptide hormone angiotensin-II-beta-amide and its antibodies by using chemically modified bacteriophage and activated sepharose. (1970) (23)
Effect of leukocyte hydrolases on bacteria (1977) (23)
Anaphylactic shock in guinea pigs sensitized to polytyrosylgelatin. (1956) (23)
Suppression of experimental allergic encephalomyelitis by COP1--relevance to multiple sclerosis. (1989) (22)
Cellular aspects of the inverse relationship between the net charge of immunogens of antibodies elicited. (1970) (22)
The role of the thymus in a genetically controlled defect of the immune response at the carrier level. (1974) (22)
From synthetic antigens to synthetic vaccines (1983) (22)
On the immunological properties of penicillins (1971) (22)
Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens. (1988) (22)
Spectrophotometric Titration of α-Amino Acid Copolymers Containing Tyrosine1 (1956) (22)
Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate (2019) (22)
Binding of random copolymers of three amino acids to class II MHC molecules. (1999) (22)
Binding of anti‐tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastases. In vitro and in vivo studies with lewis lung carcinoma (1979) (22)
Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis (1998) (21)
Heterogeneity of the light chains of rabbit immunoglobulin G fractions and of a series of antibodies directed towards antigens of differing complexity. (1967) (21)
Differences in immune response to synthetic antigens in two inbred strains of guinea-pigs. (1967) (21)
Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis. (2004) (21)
The anticariogenic activity of glycyrrhizin: preliminary clinical trials. (1989) (21)
Water-soluble polypeptidyl gliadins. (1962) (20)
The role of oral microorganisms in the pathogenesis of periapical pathosis. I. Effect of Streptococcus mutans and its cellular constituents on the dental pulp and periapical tissue of cats. (1983) (20)
Genetic control of immune response toward the loop region of lysozyme. (1973) (20)
Suppressive activity of Cop 1 in EAE and its relevance to multiple sclerosis. (1990) (20)
Inhibition of the activity of glucosyltransferase from Streptococcus mutans by glycyrrhizin. (1987) (20)
Therapeutic vaccines: realities of today and hopes for the future. (2002) (20)
Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy (1992) (20)
Lipolytic activity of bovine growth hormone bound to sepharose beads (1972) (20)
Inflammatory cells and bacteria in pericoronal exudates from acute pericoronitis. (1986) (20)
Antigenic competition and genetic control of the immune response. A hypothesis for intramolecular competition. (1973) (20)
Dental caries and its determinants among recent immigrants from rural Ethiopia. (1992) (20)
Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor (1997) (20)
The concept of specific immune treatment against autoimmune diseases. (1999) (20)
Detection of inosine-containing transfer ribonucleic acid species by affinity chromatography on columns of anti-inosine antibodies. (1973) (20)
Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection. (2005) (19)
Antibdies of different specificities in normal rabbit sera. (1970) (19)
Appearance of Serine upon Alkaline Incubation of Iodinated Polytyrosine (1956) (19)
Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera. (1976) (19)
A functional peptide encoded in the Escherichia coli 23S rRNA (1996) (19)
Studies on the mechanism of antigenic competition: Analysis of competition between synthetic polypeptide antigens (1972) (19)
Antibodies to transfer RNA obtained with covalently linked tRNA conjugates. (1970) (18)
Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes. (1998) (18)
Synthetic copolymer 1 and myelin basic protein do not require processing prior to binding to class II major histocompatibility complex molecules on living antigen-presenting cells. (1995) (18)
Specificity of immunological tolerance to poly-DL-aalanyl proteins. (1967) (18)
Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth (2011) (18)
The Major Histocompatibility Antigens in Various Species (1970) (18)
The effect of leukocyte hydrolases on bacteria (1976) (18)
Immune response to the collagen-like synthetic ordered polypeptide (L-Pro-Gly-L-Pro)n. (1973) (18)
Cellular studies of the genetic control of immune response toward the loop region of lysozyme. (1973) (18)
A conjugate of 5-fluorouridine-poly(L-lysine) and an antibody reactive with human colon carcinoma. (1990) (18)
Inflammatory lesions and bone resorption induced in the rat periodontium by lipoteichoic acid ofStreptococcus mutans (1979) (18)
Immunomodulatory vaccines against autoimmune diseases. (2006) (18)
Studies on the types of immune responses to synthetic antigens in guinea-pigs. (1966) (17)
Inosine-coated bacteriophage T 4 . (1971) (17)
The relationship between alveolar bone loss and proximal caries in children: prevalence and microbiology. (1993) (17)
Local application of sustained-release delivery system of chlorhexidine in Down's syndrome population. (1991) (17)
An altered peptide ligand inhibits the activities of matrix metalloproteinase‐9 and phospholipase C, and inhibits T cell interactions with VCAM‐1 induced in vivo by a myasthenogenic T cell epitope (2001) (17)
New synthesis of poly-L-glutamic acid and poly-L-glutamyl proteins. (1966) (17)
Reduction in immunological manifestations of 6-aminopenicillanic acid by treatment with water-insoluble pronase. (1970) (17)
THE ROLE OF THYMOCYTES AND BONE MARROW CELLS IN DEFINING THE RESPONSE TO THE DINITROPHENYL HAPTEN ATTACHED TO POSITIVELY AND NEGATIVELY CHARGED SYNTHETIC POLYPEPTIDE CARRIERS (1973) (17)
Comparison of IgG and IgM antibodies specific for uridine. (1967) (17)
Reconstitution of genetically regulated responses against random and ordered synthetic polypeptides by methylated bovine serum albumin as analyzed by isoelectric focusing (1976) (17)
Altered Peptide Ligands of a Myasthenogenic Epitope as Modulators of Specific T‐Cell Responses (1996) (17)
Adjuvant effect of a peptidoglycan attached covalently to a synthetic antigen provoking anti-phage antibodies. (1978) (16)
ISOLATION AND FRAGMENTATION OF ANTIBODIES TO POLYTYROSYL GELATIN. (1964) (16)
Solubilization of lymphocyte and thymocyte antigens by a reversible chemical modification (1971) (16)
The genetic control of the immune response to different antigenic determinants within the synthetic polypeptide poly (His,Glu)‐polyPro–poly Lys (1974) (16)
Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+CD25+ regulatory cells (2006) (16)
Effect of leukocyte hydrolases on bacteria (1979) (16)
The Effect of Leukocyte Hydrolases on Bacteria. XI. Lysis by Leukocyte Extracts and by Myeloperoxidase of a Staphylococcus aureus Mutant Which is Deficient in Teichoic Acid, and the Inhibition of Bacteriolysis by Lipoteichoic Acid 1 (1978) (16)
The Effect of Previous Diet on Plaque pH Response to Different Foods (1988) (16)
Preparation of antisera to α‐fetoprotein making use of estradiol affinity column (1973) (16)
Genetic control of immune responses to synthetic polypeptides in mice: cellular analysis of the phenotypic correction of the Ir-3 gene defect by polyadenylic-polyuridylic acid. (1973) (16)
Periodontal diseases, caries, and microbial composition of the subgingival plaque in children: a longitudinal study. (2002) (16)
The nature of the antigen. (1996) (16)
Strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to the encephalitogenic determinant in inbred guinea pigs. (1977) (16)
INDUCTION OF IMMUNOLOGICAL TOLERANCE TOWARDS A PEPTIDE DETERMINANT WITH A NON-IMMUNOGENIC POLYPEPTIDE. (1964) (16)
Poly-p-amino-DL-phenylalanine1,2 (1954) (16)
Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine). (1980) (16)
A COMPARISON OF FRAGMENTS OF RABBIT ANTIBODIES AND NORMAL GAMMA-GLOBULIN BY THE PEPTIDE-MAP TECHNIQUE. (1964) (16)
Molecular Weight Distribution of Linear and Multichain Polyamino Acids. Statistical Analysis (1955) (15)
The Antibacterial Activity of LL-37 against Treponema denticola Is Dentilisin Protease Independent and Facilitated by the Major Outer Sheath Protein Virulence Factor (2011) (15)
Hypersensitivity to a Synthetic Polypeptide: Induction of a Delayed Reaction (1963) (15)
Cop 1 as a candidate drug for multiple sclerosis. (1997) (15)
Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library. (2000) (15)
Synthetic approaches to vaccines for infectious and autoimmune diseases. (1992) (15)
Cytotoxic activity of antibodies to a collagen‐like synthetic polytripeptide on cells in tissue culture (1973) (15)
A dual altered peptide ligand down‐regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up‐regulation of Fas–FasL‐mediated apoptosis (2006) (15)
The effect of sustained release application of chlorhexidine on salivary levels of Streptococcus mutans in partial denture wearers. (1990) (15)
Soluble antigen-antibody complexes as intermediates in the purification of antibodies in 8 molar urea. (1966) (15)
Further studies on the immunogenicity of D-amino acid polymers. (1967) (15)
Anti-cholera response elicited by a completely synthetic antigen with built-in adjuvanticity administered in aqueous solution. (1986) (15)
Role of the net electrical charge of the complete antigen in determining the chemical nature of anti-p-azobenzenearsonate antibodies. (1968) (15)
STUDIES ON THE ANTIGENIC STRUCTURE OF RIBONUCLEASE. IV. POLYALANYL RIBONUCLEASE. (1963) (15)
PASSIVE CUTANEOUS ANAPHYLAXIS IN THE GUINEA-PIG WITH RABBIT ANTIBODIES AGAINST SYNTHETIC POLYPEPTIDES. (1964) (15)
BIOLOGICAL ACTIVITY OF THE CLEAVAGE PRODUCT OF HUMAN IMMUNOGLOBULIN G WITH CYANOGEN BROMIDE (1967) (15)
INTERACTION OF PHOSPHOROTHIOATE WITH THE DISULFIDE BONDS OF RIBONUCLEASE AND LYSOZYME. (1964) (15)
Cellular analysis of the phenotypic correction of the genetically controlled low immune response to the polyproline determinant by macrophages. (1974) (15)
Isolation of Antibodies to Gelatin from Antigen-Antibody Complex by Proteolysis (1960) (15)
Priming immune response to cholera toxin induced by synthetic peptides (1986) (15)
Conversion with Polynucleotides of a Genetically Controlled Low Immune Response to a High Response in Mice Immunized with a Synthetic Polypeptide Antigen (1971) (14)
Correlation between Net Charge of Antigens and Electrophoretic Mobility of Immunoglobulin M Antibodies (1967) (14)
Effect of cleaving interchain disulfide bridges on the radius of gyration and maximum length of anti-poly(D-alanyl) antibodies before and after reaction with tetraalanine hapten. (1980) (14)
A comparative study of basic, acidic and neutral polypeptidyl RNases, including polyarginyl and polyhistidyl derivatives. (1967) (14)
Dose response and induction of tolerance to the synthetic antigen (T,G)‐A–L in adult rabbits (1971) (14)
Antibodies to yeast phenylalanine transfer ribonucleic acid are specific for the odd nucleoside ) in the anticodon loop. (1974) (14)
Studies on synthetic polypeptide antigens derived from multichain polyproline. II. Metabolism and localization. (1970) (14)
EFFECT OF A CONJUGATE OF DAUNOMYCIN AND PURIFIED POLYCLONAL OR MONOCLONAL ANTIBODIES TO RAT α‐FETOPROTEIN ON THE GROWTH OF α‐FETOPROTEIN‐PRODUCING TUMOR CELLS (1983) (14)
The interaction of leukocytes and their hydrolases with bacteria in vitro and in vivo: The modification of the bactericidal and bacteriolytic reactions by cationic and anionic macromolecular substances and by anti-inflammatory agents (1976) (14)
Structural components responsible for peptide antigenicity (2000) (14)
Genetic control of the murine cell-mediated immune response in vivo. II. H-2 linked responsiveness to the synthetic polypeptide poly(Tyr,Glu)-poly(DL-Ala)--poly(Lys). (1975) (13)
Multiple forms of the major phenylalanine specific protease in Treponema denticola. (1999) (13)
Detection of anti-p-azobenzenearsonate antibodies with chemically modified bacteriophage. (1970) (13)
Correlation between strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to encephalitogenic protein in inbred guinea pigs. (1973) (13)
Specific antibodies to dinucleotides and trinucleotides. (1972) (13)
Antibodies against polyalanyl determinants attached to negatively or positively charged carriers (1971) (12)
Clinical and microbiological effects of chlorhexidine and arginine sustained-release varnishes in the mentally retarded. (1994) (12)
The effect of sustained-release varnish of chlorhexidine in dental plastic shells on salivary Streptococcus mutans. (1991) (12)
The effect of anti‐α‐fetoprotein‐adriamycin conjugate on a human hepatoma (1990) (12)
Genetic control of immune response. The dose of antigen given in aqueous solution is critical in determining which mouse strain is high responder to poly(LTyr, LGlu)-poly(LPro)--poly(LLys) (1975) (12)
Dichotomy between the T and the B cell epitopes of the synthetic polypeptide (T,G)‐A–L (1994) (12)
IMMUNOLOGIC PROPERTIES OF URINARY PREPARATIONS OF HUMAN MENOPAUSAL GONADOTROPINS, WITH SPECIAL REFERENCE TO PERGONAL (1961) (12)
Synthesis, characterization and enzymatic properties of poly-L-lysyl ribonuclease. (1967) (12)
Stimulation in vivo and in vitro of anti-dinitrophenyl antibodies with homologous protein carriers devoid of hapten. (1972) (12)
HLA polymorphism in Moroccan Jewry. (1994) (12)
Specific fractionation of antibodies to peptide determinants. (1970) (12)
Direct binding of a synthetic multichain polypeptide to class II major histocompatibility complex molecules on antigen-presenting cells and stimulation of a specific T-cell line require processing of the polypeptide. (1991) (12)
The effect of leukocyte hydrolases on bacteria (1978) (12)
Poly-L-cyclohexylalanine and Poly-L-cyclohexylalanyl Proteins (1960) (12)
Poly(α-amino acids) - From a better understanding of immune phenomena to a drug against multiple sclerosis (1998) (11)
Role of antigenic structure in cell to cell cooperation. (1976) (11)
Characterization and partial purification of antigenic components solubilized by a reversible chemical modification from rat-thymocyte membrane. (1972) (11)
An assay of pepsin using ribonuclease as substrate. (1959) (11)
Clinical Trials of Copolymer I in Multiple Sclerosis (1984) (11)
Cell proliferation and antibody production in the secondary response in vitro towards a defined hapten (1971) (11)
Cytokine profile and T cell adhesiveness to endothelial selectins: in vivo induction by a myasthenogenic T cell epitope and immunomodulation by a dual altered peptide ligand. (2000) (11)
Surveillance of oral cultures for Enterobacteriaceae during bone marrow transplantation. (1995) (11)
INHIBITION OF TRYPSIN BY COPOLYMERS OF GLUTAMIC ACID AND OTHER AMINO ACIDS. (1964) (11)
Optical rotatory properties of poly-L-tryptophan. (1961) (11)
Clinical experience with COP‐1 in multiple sclerosis (1988) (11)
Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis (2016) (10)
The effect of leukocyte hydrolases on bacteria (1975) (10)
Detection of antibody-like structures on cell surfaces with chemically modified bacteriophages. (1971) (10)
A SYNTHETIC POLYPEPTIDE ANTIGEN DEVOID OF CHARGE. (1963) (10)
Genetic control of immune response in mice to derivatives of multichain polyproline differing in the optical configuration of component amino acids (1973) (10)
Role of a rigid polyproline spacer inserted between hapten and carrier in the induction of anti‐hapten antibodies and delayed hypersensitivity (1973) (10)
STRUCTURE AND SPECIFICITY OF SYNTHETIC POLYPEPTIDE ANTIGENS * (1970) (10)
A Dual Altered Peptide Ligand Inhibits Myasthenia Gravis Associated Responses by Inducing Phosphorylated Extracellular‐regulated Kinase 1,2 that Upregulates CD4+CD25+Foxp3+ Cells (2007) (10)
Combining sites of antibodies to L-alanine and D-alanine peptide determinants. (1965) (10)
Development of Copolymer 1 (Copaxone®) as a Specific Drug Against Multiple Sclerosis (1999) (10)
Nucleoside-specific antibodies elicited by synthetic antigens. (1965) (9)
Equine anti-hapten antibody. IV. The effect of polyalanylation on affinity. (1967) (9)
ACTIVE FRAGMENTS OBTAINED BY CLEAVAGE OF RABBIT ANTIBODY WITH CYANOGEN BROMIDE. (1965) (9)
Genetic control of immune responsiveness to poly (LPro)--poly (LLys)-derived polypeptides by histocompatibility-linked immune response genes in the rat. (1976) (9)
Specific targeting of adriamycin conjugates with monoclonal antibodies to hepatoma associated antigens to intrahepatic tumors in athymic mice (1995) (9)
The composition of subgingival microflora in two groups of children with and without primary dentition alveolar bone loss. (1996) (9)
A comparison of the antigenic specificity of random and ordered linear polypeptides composed of L-tyrosine, L-alanine and L-glutamic acid. (1971) (9)
Azo Derivatives of Some Aromatic Poly-α-amino Acids (1955) (9)
The effect of leukocyte hydrolases on bacteria (1975) (9)
Search for antibodies against the carbohydrate portion of two mouse myeloma proteins. (1970) (9)
Immune response to multichain poly-DL-alanine (1967) (9)
EFFECT OF ANTIGENIC STRUCTURE ON ANTIBODY BIOSYNTHESIS * (1971) (9)
Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies. (2011) (9)
Synthetic vaccines: present and future. (1985) (9)
Monoclonal antibodies to the synthetic adjuvant muramyl dipeptide: characterization of the specificity. (1983) (9)
Affinity and avidity of antibodies to the random polymer (T,G)-A--L and a related ordered synthetic polypeptide. (1978) (9)
Studies on synthetic polypeptide antigens derived from multichain polyproline. I. Immunogenic and tolerogenic capacity of antigens composed wholly or partly of D-amino acids. (1970) (8)
Binding of peptides of the human acetylcholine receptor alpha-subunit to HLA class II of patients with myasthenia gravis. (1995) (8)
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis (2020) (8)
Antibodies as carriers for oncostatic materials. (1980) (8)
Antigenicity of p-azobenzenearsonate-containing oligopeptides in rabbits. (1974) (8)
A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses (2006) (8)
Bacterial colonization of the parotid duct in xerostomia. (1990) (8)
Distribution of antibody activities after simultaneous immunization with two antigens (1966) (8)
Hydrogen ion titration of rabbit γ-globulin and some of its subunits (1964) (8)
Change in specificity of antibodies to a random synthetic branched polypeptide in mice tolerant to its ordered analogs. (1979) (8)
Subgingival irrigation with amine fluoride-stannous fluoride gel in treated periodontal pockets. (1994) (8)
Multichain Polyproline Coated with Histidyl and Glutamyl Residues — A Potent Synthetic Immunogen (1972) (8)
Use of a metastabilized chlorous acid/chlorine dioxide formulation as a mouthrinse for plaque reduction. (1989) (8)
Multimerization of ERBB2/HER2 specific aptamer leads to improved receptor binding. (2015) (8)
Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy. (2015) (8)
Ia-antigen-T-cell interactions for a thymus-independent antigen composed of D amino acids. (1993) (8)
Life sciences for the 21st century (2004) (7)
Preferential immune response to D-amino acid residues in poly-DL-amino acid determinants. (1965) (7)
Immunological unresponsiveness induced in adult mice to synthetic polypeptides built on multichain polyproline and multichain polyalanine. (1974) (7)
Immunogenicity of hapten conjugates of poly-D-tyrosine. (1967) (7)
CHEMICAL SYNTHESIS FOR THE UNDERSTANDING OF IMMUNE RESPONSE PHENOMENA AND FOR THEIR MEDICAL APPLICATION (1980) (7)
Nucleoside-coated bacteriophage T4: a method for the detection and characterization of anti-nucleoside antibodies. (1972) (7)
Biological properties of poly-alpha-amino acids. (1959) (7)
Resolution of mouse and human immunoglobulin G into two fractions by chromatography on diethylaminoethyl-sephadex. Relation of mouse antibody type to the antigen charge. (1969) (6)
Specificity of immunological tolerance to synthetic polypeptides. (1969) (6)
Antigenicity of dinitrophenyl polyproline (1973) (6)
Inverse relationship between net electric charge on the antigen and that on the sensitized cell in cellular immune response: demonstration with basic encephalitogen of the brain (1975) (6)
Immunogenicity and antigenic specificity of a glutaraldehyde cross-linked transfer RNA-protein conjugate. (1974) (6)
Haemagglutination-inhibition studies of the combining sites of anti-peptide antibodies in mice and rats. (1970) (6)
The mode of interaction with macrophages of two ordered synthetic polypeptides which differ in their thymus dependency. (1978) (6)
The effect of urea and guanidine on the helix content of poly-N5-(3-hydroxypropyl)-L-glutamine in aqueous-solvent systems. (1963) (6)
Antibody response to polyalanyl determinants in tolerant rabbits. (1971) (6)
The immune response of inbred strains of guinea-pigs to polylysyl rabbit serum albumin (1966) (6)
Treatment of multiple sclerosis with a synthetic polypeptide: preliminary results. (1980) (6)
The purification and characterization of an 88-kDa Porphyromonas endodontalis 35406 protease. (2001) (6)
Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice (2005) (6)
Periodontal status among adult immigrants from rural Ethiopia. (1993) (6)
Tolerance to thymus-independent antigens. Characteristics of induction of tolerance to thymus-independent synthetic polypeptides. (1974) (6)
[50] Reaction with N-carboxy-α-amino acid anhydrides. (1972) (6)
Aromatic side-chain interactions as the origin of immunological diversity in the TyrTyrGluGlu and TyrGluTyrGlu epitopes: NMR and fluorescence evidence. (1993) (5)
Effect of leukocyte hydrolases on bacteria (1979) (5)
The Role of Antigenic Structure in B Lymphocyte Activation (1975) (5)
Conformational changes induced in anti-poly(L-prolyl) antibodies by oligoproline haptens of different sizes. (1979) (5)
Preparation and enzymic characteristics of poly-DL-alanyl myosin. (1968) (5)
Role of leukocyte factors and cationic polyelectrolytes in phagocytosis of group a streptococci andCandida albicans by neutrophils, macrophages, fibroblasts and epithelial cells (1981) (5)
Cellular analysis of specificity of antibodies and of delayed type hypersensitivity responses toward some structurally related synthetic antigens: boosting is determined by specificity of T cells. (1982) (5)
Antibodies to cholera toxin synthetic peptides of increasing size and their reactivity with related toxins. (1986) (5)
Antigens and antigenicity (1969) (5)
Chemical modification of human erythrocytes by attachment of tyrosine and alanine peptides. (1966) (5)
Proceedings: Suppression of experimental allergic encephalomyelitis in rhesus monkeys by a synthetic basic copolymer. (1975) (5)
Nuclease-coated bacteriophage: a sensitive tool for studying antigenic reactivity of synthetic sequence fragments. (1973) (4)
Synthetic Vaccines of the Future (1975) (4)
Structural and microbiological evaluation of a degradable sustained-release device for use in periodontal therapy. (1991) (4)
From Proteins and Protein Models to Their Use in Immunology and Immunotherapy (2003) (4)
[69] Reaction with N-carboxy-α-amino acid anhydrides (1967) (4)
Detection of Proteins with Chemically Modified Bacteriophages (1971) (4)
The bacteriolytic effect of human dentoalveolar purulent exudates and leukocyte extracts. (1977) (4)
Cooperation of antigenic determinants in intact mice and interference by antigenic competition (1972) (4)
Lack of inverse relationship between the net charge of T-independent immunogens and the responding spleen cells. (1975) (4)
Use of immunologically modified bacteriophage T4 in detection of antibodies to nucleic acids. (1972) (4)
Phagocytosis and binding via complement receptors by salivary polymorphonuclear leukocytes (1981) (4)
Chemical studies of the combining sites of antibodies (1966) (4)
OR 6 Porphyromonas endodontalis and symptoms from teeth with endodontic infections (1999) (3)
Analysis of the role of different cell types in the genetic regulation of antibody production to the thymus‐independent synthetic polypeptide poly (DTyr, DGlu)‐poly(DPro)‐‐poly (DLys) (1975) (3)
The challenge of the combined use of synthetic antigens and synthetic adjuvants (1979) (3)
On the conformation of antibodies in the presence and absence of antigen (small-angle X-ray studies) (1978) (3)
Cancer Immunotherapy: More Is (Much) Better (2015) (3)
Disc electrophoresis patterns of the Fd fragment of rabbit immunoglobulin fractions and of purified antibodies. (1969) (3)
2-31-01 Copolymer 1 inhibits the response to myelin basic protein p84-102 by T cell receptor antagonism in addition to MHC blocking (1997) (3)
Effect of toothbrushing with a fluoride-free and fluoride-containing dentifrice on oral hygiene and number of leukocytes in the gingival fluid. (1979) (3)
Synthetic Antigens - an Insight into the Specificity of B and T Cells (1981) (3)
Highly sensitive immunoassay of proteins and other compounds with bacteriophage. (1972) (3)
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies. (2019) (3)
Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells. (1983) (3)
Bacteriolytic activity of human gingival exudate (1980) (3)
Synthetic Antigens and Vaccines (1984) (3)
Action of papain on normal rabbit immunoglobulin M. (1967) (3)
Evaluation of Multichain Polyglutamic Acid as a Possible Plasma Expander∗ (1961) (3)
Whole genomic DNA probe for detection of Porphyromonas endodontalis. (2000) (3)
Unprimed spleen cell populations recognize macrophage-bound antigen with opposite net electric charge. (1977) (3)
Immunomodulation of Myasthenia Gravis Associated Autoimmune Responses by an Altered Peptide Ligand: Mechanisms of action (2000) (3)
Structural origin of the immunological diversity of two closely related tetrapeptides: CIDNP study of TyrTyrGluGlu and TyrGluTyrGlu epitopes. (1992) (3)
Varied effects of polyadenylic-polyuridylic acid on immune responses. (1976) (3)
A polymer as an active ingredient in a drug?-?the development of Copolymer 1 as a drug against multiple sclerosis (2002) (2)
Synthetic peptides with antigenic specificity for bacterial toxins. (1986) (2)
Copolymer 1 induces suppressor T cells of the Th2 type (1996) (2)
[Clinical trial of copolymer 1 in multiple sclerosis]. (1989) (2)
A personal view of molecular immunology (1994) (2)
On the role of charge in antigen-antibody precipitin reactions. (1965) (2)
Induction of tolerance to poly-DL-alanyl ribonuclease in adult rats. (1970) (2)
Biological andChemical Characterization ofEndotoxin from Capnocytophaga sputigena (1980) (2)
Stimulation of anti‐hapten response by heterologous protein devoid of hapten (1972) (2)
Preparation of antisera to alpha-fetoprotein making use of estradiol affinity column. (1973) (2)
Ultrastructural studies of the effect of human leukocyte extracts on periodontopathic bacteria (1983) (2)
The effect of a water soluble adjuvant on the immune response to synthetic polypeptides. (1978) (2)
A tale of two peptides, TyrTyrGluGlu and TyrGluTyrGlu, and their diverse immune behaviour. (1992) (2)
My world through science (2004) (2)
THE COVALENT LINKING OF TWO NUCLEOTIDE ANALOGS TO ANTIBODIES (1985) (2)
Effect of human leukocyte extracts and gingival exudate on periodontopathic bacteria (1983) (2)
[175] Preparation of nucleoside-specific synthetic antigens (1968) (2)
Genetic control of the immune response to a thymus independent synthetic polypeptide (1974) (2)
Fine specificity of antibodies to the synthetic polypeptide poly(L-tyrosine, L-glutamic acid)-poly(DL-alanine)--poly(L-lysine) and its ordered analogs as followed by solid-phase radioimmunoassay. (1983) (2)
Antiviral antibodies obtained with aqueous solution of a synthetic antigen. (1980) (2)
NEUROTOXIC PROTEIN OF VIPERA PALESTINAE VENOM (1967) (2)
Polymeric drugs as immunomodulatory vaccines against multiple sclerosis (1993) (2)
The effect of anti-alpha-fetoprotein-adriamycin conjugate on a human hepatoma. (1990) (2)
Clinical trials of a synthetic polypeptide (Copolymer I) for the treatment of multiple sclerosis (1984) (2)
Hospital personnel with penicillin-resistant Streptococcus viridans. A case for special consideration in the prevention of bacterial endocarditis. (1984) (2)
Immunomodulation of experimental allergic encephalomyelitis by oral administration of Copolymer 1 (Copaxone®) (1998) (1)
Dominant epitopes and synthetic peptides in myasthenia gravis. (1995) (1)
[The role of conformation in antigenicity]. (1972) (1)
Penicillin Antibodies and Immunoglobulin Production in Newborn Infants: Studies with Chemically Modified Bacteriophage (1973) (1)
Use of synthetic polypeptides and peptidyl proteins in studies of immunological tolerance. (1965) (1)
Immunology and Nucleic Acids (1969) (1)
Effect of phytohemagglutinin on thymidine incorporation and antibody production in the secondary response in vitro towards a defined hapten (1971) (1)
Modulation of human lymphocyte transformation by bacterial products and leukocyte lysates (1982) (1)
The in vitro effect of lithium on growth and adherence of Streptococcus mutans 6715. (1988) (1)
Genetic control and immunity. (1972) (1)
Copolymer 1 suppresses chronic-relapsing eae induced in mice by PLP encephalitogenic peptides and interferes with the immune response to these peptides (1995) (1)
Historic recollections: From polymers and proteins to autoimmunity and cancer. (2015) (1)
The Consequences of New Approaches in Parasitological Research (1983) (1)
In vitro proliferative reactions by lymphocytes from both responder and "low" responder mice to (T,G)-A--L. (1976) (1)
From synthetic antigens to synthetic vaccines. (1981) (1)
Sela Role of Treponema Denticola in Periodontal Diseases (2001) (1)
Selective depletion of T regulatory cells reduces but does not eliminate the ability of glatiramer acetate to ameliorate experimental autoimmune encephalomyelitis (P2.192) (2015) (1)
Cleavage of horse immunoglobulin by cyanogen bromide. (1968) (1)
The Role of non-specific immunity in the prevention and treatment of cancer : proceedings of a study week at the Pontifical Academy of Sciences, October 17-21, 1977 (1979) (1)
Synthetic Polypeptides as Models for Proteins (1962) (1)
Antiviral effect on MS2 coliphage obtained with a synthetic antigen ( vaccine / viral coat protein / peptide synthesis / peptide-carrier conjugate / phage neutralization ) (1)
Proceedings: Strain differences in the immune response to the encephalytogenic determinant in inbred guinea pigs. (1975) (1)
Branched polyamino acids (1955) (1)
Synthetic vaccines for infectious and autoimmune diseases. (1996) (1)
3-31-25 Suppression of experimental allergic encephalomyelitis by oral administration of copolymer 1 (copaxone®) (1997) (1)
The Ordered Polymer (Pro‐Gly‐Pro)n an Immunological Model for Collagen (1974) (1)
ON THE UNPREDICTABILITY OF INDIVIDUAL RESEARCH (2008) (0)
ROLEOFTREPONEIAU DENTICOLA INPERIODONTAL DISEASES (2001) (0)
Antibodies to Yeast Phenylalanine Transfer Ribonucleic Acid Are Specific for the Odd Nucleoside Y in the Anticodon Loop ( Y base / tRNA fractionation ) (0)
On research in a small country (2001) (0)
Antigen-Antibody Relationship (1973) (0)
Vaccine against cholera and against heat-labile e. coli toxin (1984) (0)
On antibody formation to defined determinants. (1971) (0)
Bystander suppression of experimental autoimmune encephalomyelitis by Th2 suppressor cells specific to copolymer 1 (1997) (0)
On the notion of synergy of monoclonal antibodies as drugs (2009) (0)
Binding of histamine- and other ligand-conjugated macromolecules to lymphocytes (1975) (0)
On research in a small country. Basic research and its practical applications. (2001) (0)
In memory of Shneior (2003) (0)
Characterization ofFibrinolytic Activities ofTreponema denticola (1994) (0)
Verbeserungen in compositions of copolymers containing copolymer-1 (1995) (0)
Improvements copolymer-1 copolymer compositions. (1995) (0)
Peptides and Polypeptides as Immunomodulators and Their Consequential Therapeutic Effect in Multiple Sclerosis and Other Autoimmune Diseases (2011) (0)
fixed muramyl peptides on peptide polymers and drugs containing (1979) (0)
Treponema denticola. Characterization of fibrinolytic activities of (2013) (0)
Israeli Division (1988) (0)
Arthritis-Associated HLA-DR Molecules Sclerosis- and Rheumatoid Binding Motifs of Copolymer 1 to Multiple (1999) (0)
I. DIFFERENCES IN FREQUENCY OF SPLENIC PRECURSOR CELL~ SPECIFIC FOR A SYNTHETIC POLYPEPTIDE DERIVED FROM MULTICHAIN POLYPROLINE (2003) (0)
Pharmaceutical compositions with sustained release (1988) (0)
The relationship between HLA antigens and Bermuda grass hayfever (1978) (0)
HYDROGEN ION TITRATION OF RABBIT GAMMA-GLOBULIN AND SOME OF ITS SUBUNITS. (1964) (0)
New perspectives in biology : proceedings of a symposium held at the Weizmann Institute of Science on the occasion of the inauguration of the Ullmann Institute of Life Sciences, June 10-17,1963 (1964) (0)
Effects of interchain disulfide bridges on the radius of gyration and maximum length of antibodies before and after reaction with the specific hapten (1981) (0)
Compositions pharmaceutiques comportant un copolymere peptidique de synthese et servant a la prevention des troubles dus a la reaction greffe contre hote (1996) (0)
Sustained release drug. (1987) (0)
Enhanced myelination in autoimmunity and in normal development induced by immunomodulatory treatment (2014) (0)
T Cell Epitopes of Synthetic Antigens and of Antigens Related to Autoimmune Diseases (1993) (0)
Induction of Th2 suppressor T cells by daily subcutaneous injections of Copolymer 1 (Copaxone®) (1998) (0)
The copolymer-1 copolymers improvements mixtures (1996) (0)
[USE OF SYNTHETIC POLYPEPTIDES IN THE STUDY OF ANTIGENICITY]. (1964) (0)
The relationship of IgG and IgA in serum, saliva and gingival exudate. (1988) (0)
Pilot trial of Cop 1 in chronic progressive multiple sclerosis: Preliminary report (1989) (0)
Methods and compositions for cancer therapy and for the predictability of reactions to this treatment (1992) (0)
THE FIGHT AGAINST DISEASES : COMMENTS RELATED TO “ SCIENCE FOR MAN AND MAN FOR SCIENCE ” (2013) (0)
Some reflections on autoimmunity. (1989) (0)
The Involvement of Myasthenogenic T-cell Epitopes and Their Analogs in the Clinical Manifestations and Treatment of Myasthenia Gravis (1999) (0)
CELLULAR BASIS O F THE G ENETIC CONTROL OF IMMUNE RESPONSES TO SYNTHETIC P OLYPEPTIDES I. DIFFERENCES IN FREQUENCY OF SPLENIC PRECURSOR CELL~ SPECIFIC FOR (1970) (0)
Mechanism and specificity GVHD modulation by the synthetic copolymer GLAT (1997) (0)
Treatment with Oral Laquinimod Augments the In Situ Expression of Brain-Derived Neurotrophic Factor and Reduces CNS Injury (P02.106) (2012) (0)
Pharmaceutical preparations having sustained release (1988) (0)
Proceedings: Immunological cross-reactivity of antibodies to a synthetic undecapeptide of carcino-embryonic antigen with the intact protein and with human sera. (1975) (0)
CHALLENGES AND ACHIEVEMENTS IN INFECTIOUS AND AUTOIMMUNE DISEASES (2013) (0)
Improvements in compositions of copolymers containing copolymer-1 (1995) (0)
Genetic control of the immune response to ordered peptides of tyrosine and glutamic acid. (1976) (0)
Cellular basis of genetic control of immunity to synthetic polypeptides based on multichain poly-proline (1970) (0)
Proceedings: Lack of inverse relationship between the net charge of thymus-independent immunogens and the responding spleen cells. (1975) (0)
The Scientific Legacy of the 20 th Century Therapeutic Vaccines Against Cancer and Autoimmune Diseases (2013) (0)
ALPHA-FETOPROTEIN: ITS DIAGNOSTIC SPECIFICITY AND THERAPEUTIC USE OF ITS ANTIBOBY (1987) (0)
CORRECTION (2005) (0)
Clustering of MHC class II molecules on antigen presenting cells following binding of copolymer 1 and myelin basic protein (1997) (0)
8.14 – Copaxone (2007) (0)
Editorial and military censors (1996) (0)
CHAPTER 13 – Protein Conformation and Biological Function: From Ribonuclease to Antigens and Antibodies (1984) (0)
A process for the preparation of purified 6-aminopenicillanic acid, penicillins and (1969) (0)
Ephraim Katchalski‐Katzir at 80 (1996) (0)
Effect of Drinking Water with and Without Fluoride on the Mineralization of the Rat Incisor (1974) (0)
Astrocyte deformation and neurovascular disruption — Pathological mechanism that mediate neuronal injury and cortical damage in experimental autoimmune encephalomyelitis (2014) (0)
Anti-tumor agent and process for its preparation (1976) (0)
Treatment of multiple sclerosis by ingestion of copolymer-1 (1998) (0)
Immunology reviews, vol. 1, Soviet medical reviews, section D: Edited by R. V. Petrov. Harwood Academic Publishers, Chur, Switzerland, 1987. 443 pp (1989) (0)
IMMUNE RESPONSE (Ir) GENE SYSTEMS (1976) (0)
NATURE OF IMMUNE TOLERANCE BY MEANS OF SYNTHETIC POLYPEPTIDE ANTIGENS. (1966) (0)
Cellular Basis of the Genetic Control of Immune Responses**Supported in part by Agreement 06-035 with the National Institutes of Health, U. S. Public Health Service. (1971) (0)
Improvements in compositions containing copolymers kopolymer-1 (1995) (0)
A matter of priorities (1985) (0)
Can remyelination be enhanced by immunomodulatory therapeutic modality (2018) (0)
Overdentures for patients who are chronically ill: a 4-year follow-up. (1989) (0)
CELL FRACTIONATION OVER CHARGED COLUMNS (2003) (0)
Anaphylactic Shock in Guinea Pigs Sensitized to Polytyrosylgelatin (1956) (0)
T cell epitopes: synthetic antigens and multiple sclerosis. (1992) (0)
Magnetic Resonance Imaging (MRI) Characterization of the Therapeutic Effect of Glatiramer Acetate in Different Models of Experimental Autoimmune Encephalomyelitis (EAE) (P05.109) (2012) (0)
delayed release pharmaceutical compositions. (1987) (0)
Pioneer of hematopoietic colony-stimulating factors: Leo Sachs (1924–2013) (2014) (0)
The copolymer-1 copolymer compositions of the improvements (1996) (0)
Proceedings: The immune response potential of inbred mouse strains to two ordered peptides of tyrosine and glutamic acid as compared with their response to random (T,G)-A--L. (1975) (0)
Methods and compositions for cancer treatment and prognosis of reactions to those indicated treatments. (1992) (0)
Topics in basic immunology (1969) (0)
Specific inhibition by the synthetic copolymer COP-1 of human T cell lines specific to myelin basic protein (1991) (0)
The antigens. Volume IV. (1977) (0)
[Preparation and preoperties of poly-DL-alanyl derivatives of a trypsin inhibitor Kunitz and Northrop inhibitor)]. (1968) (0)
Shape and volume of anti‐Poly‐d‐alanyl antibodies in the presenc e and absence of tetra‐d‐alanine as followed by small‐angle X‐ray scattering (1974) (0)
Israeli Division of the International Association for Dental Research — Abstracts of Papers Presented (1977) (0)
Bacteriophage protein conjugates, their preparation and use for the detection and quantitative determination of proteins (1970) (0)
COPOLYMER 1 INHIBITS MANIFESTATIONS OF GRAFT REJECTION1 (2001) (0)
Antibodies toYeastPhenylalanine Transfer Ribonucleic AcidAreSpecific fortheOddNucleoside Y intheAnticodon Loop (1974) (0)
The responsibility of scientists — towards scientists (1977) (0)
RP-HPLC METHOD FOR QUANTITATIVE ESTIMATION OF GLATIRAMER ACETATE FOR INJECTION IN PHARMACEUTICAL DOSAGE (2012) (0)
Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen , with the intact protein and with human sera ( synthetic antigen / bacteriophage inactivation / adenocarcinomas ) (0)
Pharmaceutical compositions containing synthetic peptidcopolymerisate, for the prevention of GVHD (1996) (0)
Traitements combines comportant des copolymeres peptidiques synthetiques destines a la prevention d'un rejet de greffe (2004) (0)
Specific cytotoxicity of drugs chemically linked to antibody. (1975) (0)

This paper list is powered by the following services:

Other Resources About Michael Sela

en.wikipedia.org

What Schools Are Affiliated With Michael Sela?

Michael Sela is affiliated with the following schools:

Image Attributions

Image Source for Michael Sela